Emerald Advisers portfolio
Type not verifiedPortfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Aug 5, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Emerald Advisers reported a $4.2 bn portfolio of 235 companies (237 positions, counting each share class separately) to the SEC as of the end of Q2 2026. Its largest positions are TVTX, CDNL, MRCY. During the quarter it opened Legence and Sensient Technologies and exited BridgeBio Pharma.
Sections with a free account
What changed this quarter
209 positions with a change (22 new, 73 added to, 77 trimmed, 37 sold); also, 6 entered through an IPO, 2 exited through an acquisition or merger. 12 are listed here: those of 0.5 points of the portfolio or more (up to 12).
- Bloom Energy−99%fewer sharesReduced2.3% → 0.1%
- TTM Technologies−70%fewer sharesReduced2.3% → 1.0%
- Guardant Health−57%fewer sharesReduced2.5% → 1.3%
- Fabrinet−99%fewer sharesReduced1.8% → under 0.1%
- Legence+1.3 ppof portfolioNew— → 1.3%
- Sensient Technologies+1.1 ppof portfolioNew— → 1.1%
- Corcept Therapeutics+264%more sharesIncreased0.3% → 1.5%
- Modine Manufacturing−46%fewer sharesReduced2.6% → 1.3%
- Credo Technology Group Holding−96%fewer sharesReduced1.5% → 0.1%
- Axcelis Technologies+243%more sharesIncreased0.3% → 1.5%
- Terex+0.9 ppof portfolioNew— → 0.9%
- BridgeBio Pharma−0.9 ppof portfolioSold out1.2% → —
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- Travere TherapeuticsTVTX2.1%
- Cardinal Infrastructure GroupCDNL1.9%
- Mercury SystemsMRCY1.8%
- AARAIR1.8%
- VSEVSEC1.7%
- Kulicke and Soffa IndustriesKLIC1.7%
- ArganAGX1.7%
- CECO EnvironmentalCECO1.6%
- Corcept TherapeuticsCORT1.5%
- LivaNovaLIVN1.5%
- SemtechSMTC1.5%
- InterdigitalIDCC1.5%
- Esco TechnologiesESE1.5%
- Axcelis TechnologiesACLS1.5%
- PDF SolutionsPDFS1.5%
Portfolio by sector
- ● Information Technology 31%
- ● Health Care 22%
- ● Industrials 22%
- ● Consumer Discretionary 9%
- ● Financials 9%
- ● Energy 3%
- ● Materials 2%
- ● Consumer Staples 2%
- ● Real Estate 1%
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Type not verified: we have not assigned a type because we found no document that is enough to tell. Most 13F filers are in this situation: we only review in depth those that meet the portfolio criteria.
Not counted as a concentrated manager: its portfolio is not within 5 to 100 positions; its top 10 positions are under 45%. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided
Managers of a similar size
A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.
- Altarock PartnersInvestment firm · $4.2 bn
- Marshfield AssociatesInvestment firm · $4.3 bn
- Trian Fund ManagementInvestment firm · $4.2 bn
- Contour Asset ManagementInvestment firm · $4.2 bn
- Hill City CapitalInvestment firm · $4.3 bn
- AKO Capital LLPInvestment firm · $4.3 bn